Institution profile

茜道頓堀クリニック

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 02E2506034 +5

Location

Prefecture
Osaka
Address
大阪市中央区島之内2-2-2スターレジデンス心斎橋東1F2F

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • 医療法人社団優恵会 特定認定再生医療等委員会
  • 医療法人 清悠会 認定再生医療等委員会
  • 医療法人清悠会 認定再生医療等委員会
  • +1

Public score

69.8/ 100

A · Review level
25.0 / 30
B · Technologies
22.4 / 35
C · Coverage
17.9 / 25
D · Class I / II technologies
4.6 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 69.8
Public score →100

Registered technologies (6)

Stem cells (all sources) 1
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪組織由来間葉系幹細胞を用いた内臓脂肪症候群に起因する動脈硬化症治療Stem cells (all sources)Adipose-derived stem cellsClass II
Adipose-derived stem cells 1
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪組織由来間葉系幹細胞を用いた内臓脂肪症候群に起因する動脈硬化症治療Stem cells (all sources)Adipose-derived stem cellsClass II
PRP and platelet-derived 2
Registered technologies · Japanese originalTechnology areasPlan classification
多血小板血漿を用いた毛髪組織再生療法PRP and platelet-derivedHairClass III
多血小板血漿を用いた老化や外部刺激等による肌萎縮再生治療PRP and platelet-derivedSkinClass III
NK and immune cells 2
Registered technologies · Japanese originalTechnology areasPlan classification
複合免疫療法(がんの治療、予防および免疫力改善を期待する複合型免疫細胞療法)NK and immune cellsClass III
悪性腫瘍の予防に対する自家NK細胞療法NK and immune cellsClass III
Hair 1
Registered technologies · Japanese originalTechnology areasPlan classification
多血小板血漿を用いた毛髪組織再生療法PRP and platelet-derivedHairClass III
Skin 2
Registered technologies · Japanese originalTechnology areasPlan classification
自己線維芽細胞を用いた再生医療技術による皮膚醜形治療SkinClass II
多血小板血漿を用いた老化や外部刺激等による肌萎縮再生治療PRP and platelet-derivedSkinClass III

Certified committee for regenerative medicine

  • 医療法人社団優恵会 特定認定再生医療等委員会
  • 医療法人 清悠会 認定再生医療等委員会
  • 医療法人清悠会 認定再生医療等委員会
  • 同仁会認定再生医療等委員会

Public document number

  • 02E2506034
  • 03E2602002
  • 01E2312015
  • 01E2312016
  • 01E2401019
  • 02E2409024
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
自己脂肪組織由来間葉系幹細胞を用いた内臓脂肪症候群に起因する動脈硬化症治療Class II医療法人社団優恵会 特定認定再生医療等委員会02E2506034
自己線維芽細胞を用いた再生医療技術による皮膚醜形治療Class II医療法人社団優恵会 特定認定再生医療等委員会03E2602002
多血小板血漿を用いた老化や外部刺激等による肌萎縮再生治療Class III医療法人 清悠会 認定再生医療等委員会01E2312015
多血小板血漿を用いた毛髪組織再生療法Class III医療法人 清悠会 認定再生医療等委員会01E2312016
悪性腫瘍の予防に対する自家NK細胞療法Class III医療法人清悠会 認定再生医療等委員会01E2401019
複合免疫療法(がんの治療、予防および免疫力改善を期待する複合型免疫細胞療法)Class III同仁会認定再生医療等委員会02E2409024

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor